GlassScriptPhysician profile
Nichole Denee Ruffner
NPI 1386906428
$631.28
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $42.70 · 2022: $226 · 2023: $246 · 2024: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $362.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $279.76 | 2022-2024 | Acessa Provu System, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Coopersurgical, INC. | $65.81 | 2022-2023 | Paragard T 380a |
| Myovant Sciences INC. | $62.61 | 2022 | |
| Evofem Biosciences, INC. | $54.42 | 2022 | |
| Exact Sciences Corporation | $40.89 | 2023-2024 | Cologuard Collection Kit |
| Astellas Pharma US INC | $37.36 | 2023-2024 | Veozah |
| Shield Therapeutics INC | $27.64 | 2023 | Accrufer |
| Pfizer INC. | $20.09 | 2022 | |
| Roche Diagnostics Corporation | $16.10 | 2021 | |
| Merck Sharp & Dohme LLC | $14.79 | 2021 | |
| Organon LLC | $11.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nichole Ruffner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.